Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports


The Shrimp Disease Diagnostics Market is expected to grow on a persistent note in the future. With AI making its mark everywhere, how could the healthcare vertical be left behind? Abnormalities in the medical scans could be easily spotted by radiologists with the help of machine learning. Likewise, the healthcare vertical is poised to develop on a ravishing note with technological advancements on the anvil in the next decade.

Cultured shrimps or farm-grown shrimps are considered for diagnostic tests, and the shrimp disease diagnostics comprise of reagents and kits that are used to diagnose viral diseases in shrimps. The global market for shrimp disease diagnostics registered revenues worth US$ 360 Mn in the year 2018, according to a recent research study of Persistence Market Research (PMR).

Get Sample Copy of this Report@

The shrimp disease diagnostics market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA and Emerging Countries such as China, Thailand and India. Due to the high viral-borne endemic shrimp diseases, countries such as China, Thailand, and India are estimated to be the fastest-growing regional markets for shrimp disease diagnostics, and are poised to offer significant opportunities.

With a large number of ongoing research initiatives pertaining to shrimp disease, the demand for shrimp disease diagnostics is estimated to grow significantly over the forecast period. Moreover, mergers & acquisitions and research-based collaboration agreements by key manufacturers in the shrimp disease diagnostics market are also among factors estimated to fuel the growth of the market.

Company Profile

  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab – Ind Resource Sdn Bhd.
  • Auro Biotechnologies

Request for Methodology@

Assay-based Kits Remain High Selling

The market for shrimp disease diagnostics comprises of assay-based kits and rapid testing kits. Assay-based kits are used for qualitatively assessing and quantitatively measuring the amount or functional activity of a target entity (shrimp virus) in a sample. Rapid tests are tailored during the preliminary screening of a target entity, and are very useful in resource-limited settings. Rapid tests produce results of high quality and are easy to perform with a quick output (10 minutes to 2 hours).

Rapid tests are based on agglutination and many immunological techniques. According to PMR, assay-based kits are expected to hold a prominent position in the global shrimp disease diagnostics market, as compared to reagent kits, in terms of revenue with a global market share of about 60% in 2019.

Over the years, shrimp disease diagnostic products have become attractive assay kits as compared to manual assays. The increased demand for shrimp disease diagnostics reagent kits can be attributed to their accuracy, high throughput, and reliable results, which can be achieved in a fraction of the time. Furthermore, the emergence of third-generation DNA-based diagnostic tools have also revolutionized the shrimp disease diagnostics market for quick disease diagnosis. Many studies on the efficacy comparison of manual and shrimp disease diagnostics reagent kits have shown that the latter provides high-throughput results with a high rate of accuracy and reproducibility.

Major players in the shrimp disease diagnostics market are concentrating their efforts on investing in research and development as well as to introduce new kit-based products into the market, which are not only more affordable, but also reliable for small pathology testing laboratories. In addition, several technological advancements in molecular-based diagnostics are currently under development, which will find applications in a wide range of marine and aquaculture-based studies.

Access Full Report@

Aquaculture Farming Picking Pace in Developing Countries

Macro-economic factors, such as favorable government regulations and policies for start-up companies to set up their manufacturing hubs, are estimated to fuel the growth of the shrimp disease diagnostics market. Moreover, increase in the number of aquaculture and marine laboratories is also expected to boost the demand for shrimp disease diagnostics. Furthermore, the growth of the healthcare sector as well as aquaculture farming in emerging nations is also estimated to fuel the growth of the shrimp disease diagnostics market. For instance, according to the World Bank, in 2016, China’s healthcare expenditure was 4.9% of the GDP, and it is anticipated to double by 2020.

The shrimp disease diagnostics market report offers a comprehensive taxonomy of the shrimp disease diagnostics market based on the reagents kit, disease type, end user, and region. Based on the reagents kit type, the global shrimp disease diagnostics market is segmented into rapid testing kits and assay-based kits.

Based on disease type, the shrimp disease diagnostics market is further classified White Spot Syndrome Virus (WSSV ), Taura Syndrome Virus (TSV), Yellow Head/Gill Associated Virus (YHV/GAV), Infectious Hypodermal and Hematopoietic Virus (IHHNV), Hepatopancreatic Parvovirus (HPV), Monodon Baculovirus (MBV), Infectious Myonecrosis Virus (IMNV), Necrotising Hepatopancreatitis Bacteria (NHP-B), Mourilyan Virus (MoV) and Early Mortality Syndrome (EMS). With so many viral-borne shrimp diseases and opportunities, the shrimp disease diagnostics market also offers significant potential for small and emerging players to invest in the market.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales –
Website –


Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts